GlassScriptPhysician profile
Sunil P Perera
NPI 1417039371
$1,659.74
in general payments reported to CMS, 2019-2025
19 companies · $319 in 2025
The $319 reported for 2025 was less than what a typical Allergy provider received nationally (typical 2025 total: $1,129).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2021: $90.93 · 2022: $12.50 · 2023: $586 · 2024: $408 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,234 · Education: $79.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,233.73 |
| Education | $79.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $274.32 | 2019-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $200.48 | 2023-2025 | Tezspire, Airsupra |
| Blueprint Medicines Corporation | $168.09 | 2023-2025 | Ayvakit |
| Takeda Pharmaceuticals U.S.A., INC. | $148.06 | 2023-2024 | Cuvitru, Takhzyro |
| Genzyme Corporation | $136.06 | 2023-2025 | |
| Shire North American Group INC | $121.87 | 2019 | |
| Kaleo, INC. | $105.38 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $79.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $69.33 | 2023-2025 | |
| Optinose US, INC. | $54.13 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $51.11 | 2023-2024 | Dupixent |
| Pharming Healthcare, INC. | $45.37 | 2025 | Ruconest |
| Csl Behring | $40.06 | 2024 | Hizentra |
| Biocryst US Sales Co., LLC | $36.61 | 2024 | Orladeyo |
| Phadia US INC. | $36.01 | 2023-2024 | Immunocap |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bio Products Laboratory USA, INC. | $30.27 | 2022-2023 | Gammaplex, Coagadex |
| Genentech USA, INC. | $24.92 | 2021 | |
| Octapharma USA, INC. | $22.72 | 2021 | |
| Hikma Pharmaceuticals USA | $15.95 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Perera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.